SZ 363 Pill - yellow capsule/oblong
Pill with imprint SZ 363 is Yellow, Capsule/Oblong and has been identified as Repaglinide 2 mg. It is supplied by Sandoz Inc.
Repaglinide is used in the treatment of Diabetes, Type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ 363
Repaglinide
- Imprint
- SZ 363
- Strength
- 2 mg
- Color
- Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-5150 (Discontinued)
- Inactive Ingredients
-
corn starch,
calcium phosphate dibasic anhydrous,
glycerin,
magnesium stearate,
meglumine,
microcrystalline cellulose,
poloxamer 188,
polacrilin potassium,
magnesium silicate,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about repaglinide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.